Omega-3 polyunsaturated fatty acid (PUFA) status in major depressive disorder with comorbid anxiety disorders

Journal of Clinical Psychiatry

Volumn 74, Issue 7, 2013, Pages 732-738

  Liu, Joanne J ^a   Galfalvy, Hanga C ^b   Cooper, Thomas B ^a,b,c   Oquendo, Maria A ^b   Grunebaum, Michael F ^b   Mann, J John ^a,b   Sublette, M Elizabeth ^b,c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; DSM-IV; FATTY ACID BLOOD LEVEL; FEMALE; HAMILTON SCALE; HUMAN; MAJOR DEPRESSION; MALE; MOOD DISORDER; PRIORITY JOURNAL; VOLUNTEER;

EID: 84881004202     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.12m07970     Document Type: Article

References (90)

1. Kitajka K, Sinclair AJ, Weisinger RS, et al. Effects of dietary omega 3-polyunsaturated fatty acids on brain gene expression. Proc Nati Acad Sci USA. 2004;101(30):10931-10936.
2. Shaikh SR. Biophysical and biochemical mechanisms by which dietary N 3-polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts. J Nutr Biochem. 2012;23(2):101-105.
3. Yang R, Chiang N, Oh SF, et al. Metabolomics lipidomics of eicosanoids and docosanoids generated by phagocytes. Curr Protoc Immunol. 201-1;95-:14.26.1-14.26.26.
4. Calder PC. n 3-polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(suppl):15055-1519S.
5. US Department of Health and Human Services and US Department of Agriculture. Nutrition and Your Health: Dietary Guidelines for Americans. Dietary Guidelines Advisory Committee Meeting. Washington, DC. 2004. http://www.health.gov/dietaryguidelines/dga200S/dgacol2004minutes.pdf. Accessed December S, 2012.
6. Singh RB, Niaz MA, Sharma JP, et al. Randomized, double blind, placebo controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival 4. Cardiovasc Drugs Ther. 1997;11(3):485-491.
7. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Dietary supplementation with n 3-polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial. Lancet. 1999;354(9177):447-455.
8. Simopoulos AP. Omega 3-fatty acids in inflammation and autoimmune diseases.J Am Coil Nutr. 2002;21(6):495-505.
9. Mazza M, Pomponi M, Janiri L, et al. Omega 3-fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry. 2007;3-1(1): 12-26.
10. Tiemeier H, van Tuijl HR, Hofman A, et al. Plasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study. Am J Clin Nutr. 2003;78(1):40-46.
11. Frasure Smith N, Lespérance F, Julien P. Major depression is associated with lower omega 3-fatty acid levels in patients with recent acute coronary syndromes. Biol Psychiatry. 2004;55(9):891-896.
12. Féart C, Peuchant E, Letenneur L, et al. Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three City Study. Am J Clin Nutr. 2008;87(5):1156-1162.
13. Dinan T, Siggins L, Scully P, et al. Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res. 2009;43(4):471-476.
14. Rees AM, Austin M Owen C, et al. Omega 3-deficiency associated with perinatal depression: case control study. Psychiatry Res. 2009;166(2-3): 254-259.
15. Maes M, Christophe A, Delanghe J, et al. Lowered omega 3-polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients. Psychiatry Res. 1999;85(3):275-291.
16. Riemer S, Maes M, Christophe A, et al. Lowered omega 3-PUFAs are related to major depression, but not to somatization syndrome. J Affect Disord. 2010;123(1-3):173-180.
17. Schins A, Crijns HJ, Brummer RJ, et al. Altered omega 3-polyunsaturated fatty acid status in depressed post myocardial infarction patients. Acta Psychiatr Scand. 2007;115(1):35-40.
18. Conklin SM, Manuck SB, Yao JK, et al. High omega 6-and low omega 3-fatty acids are associated with depressive symptoms and neuroticism. Psychosom Med. 2007;69(9):932-934.
19. Adams PB, Lawson S, Sanigorski A, et al. Arachidonic acid to eicosapentaenoic acid ratio in blood correlates positively with clinical symptoms of depression. Lipids. 1996;31(suppl):5157-S161.
20. Amin AA, Menon PA, Reid KJ, et al. Acute coronary syndrome patients with depression have low blood cell membrane omega 3-fatty acid levels. Psychosom Med. 2008;70(8):856-862.
21. Edwards R, Peet M, Shay J, et al. Omega 3-polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients. J Affect Disord. 1998;48(2-3):149-155.
22. McNamara RK, Jandacek R, Rider T, et al. Selective deficits in erythrocyte docosahexaenoic acid composition in adult patients with bipolar disorder and major depressive disorder. J Affect Disord. 2010;126(1-2):303-311.
23. Peet M, Murphy B, Shay J, et al. Depletion of omega 3-fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry. 1998;43(5):315-319.
24. Mamalakis G, Tornaritis M, Kafatos A. Depression and adipose essential polyunsaturated fatty acids. Pro staglandins Leukot Essent Fatty Acids. 2002;67(5):311-318.
25. Mamalakis G, Kalogeropoulos N, Andrikopoulos N, et al. Depression and long chain n 3-fatty acids in adipose tissue in adults from Crete. Eur J Clin Nutr. 2006;60(7):882-888.
26. Mamalakis G, Kiriakakis M, Tsibinos G, et al. Depression and serum adiponectin and adipose omega 3-and omega 6-fatty acids in adolescents. Pharmacol Biochem Behav. 2006;85(2):474-479.
27. Sarri KO, Linardakis M, Tzanakis N, et al. Adipose DHA inversely associated with depression as measured by the Beck Depression Inventory. Prostaglandins Leukot Essent Fatty Acids. 2008;78(2):117-122.
28. Papandreou C, Schiza SE, Tsibinos G, et al. Gluteal adipose tissue polyunsaturated fatty acids profiles and depressive symptoms in obese adults with obstructive sleep apnea hypopnea syndrome: a cross sectional study. PharmacolBiochem Behav. 2011;98(2):316-319.
29. Lin PY, Huang SY, Su KP. A meta analytic review of polyunsaturated fatty acid compositions in patients with depression. Biol Psychiatry. 2010;68(2):140-147.
30. da Silva TM, Munhoz RP, Alvarez C, et al. Depression in Parkinsons disease: a double blind, randomized, placebo controlled pilot study of omega 3-fatty acid supplementation. J Affect Disord. 2008;1-11(2-3):35-1-359.
31. Frangou S, Lewis M, McCrone P. Efficacy of ethyl eicosapentaenoic acid in bipolar depression: randomised double blind placebo controlled study. Br J Psychiatry. 2006;188(.1):46-50.
32. Nemets B, Stahl Z, Belmaker RH. Addition of omega 3-fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder. Am J Psychiatry. 2002;159(3):477-479.
33. Nemets H, Nemets B, Apter A, et al. Omega 3-treatment of childhood depression: a controlled, double blind pilot study. Am J Psychiatry. 2006;163(6):1098-1100.
34. Peet M, Horrobin DF. A dose ranging study of the effects of ethyl eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Arch Gen Psychiatry. 2002;59(10):913-919.
35. Rondanelli M, Giacosa A, Opizzi A, et al. Effect of omega 3-fatty acids supplementation on depressive symptoms and on health related quality of life in the treatment of elderly women with depression: a double blind, placebo controlled, randomized clinical trial. J Am Coil Nutr. 2010;29(1):55-64.
36. Su KR Huang SY, Chiu CC, et al. Omega 3-fatty acids in major depressive disorder: a preliminary double blind, placebo controlled trial. Eur Neuropsychopharmacol. 2003;13(4) :267-271.
37. Su KR Huang SY, Chiu TH, et al. Omega 3-fatty acids for major depressive disorder duriog pregoaocy: results from a randomized, double blind, placebo controlled trial. J Clin Psychiatry. 2008;69(4):644-651.
38. Carney RM, Freedland KE, Rubin EH, et al. Omega 3-augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA. 2009;302(15):1651-1657.
39. Doornbos B, van Goor SA, Dijck Brouwer DA, et al. Supplementation of a low dose of DHA or DHA + AA does not prevent peripartum depressive symptoms in a small population based sample. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(1-):49-52.
40. Freeman MP, Davis M, Sinha P, et al. Omega 3-fatty acids and supportive psychotherapy for perinatal depression: a randomized placebo controlled study. J Affect Disord. 2008;11O(1-2):142-148.
41. Grenyer BF, Crowe T, Meyer B, et al. Fish oil supplementation in the treatment of major depression: a randomised double blind placebo controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31-(7): 1393-1396.
42. Marangell LB, Martinez JM, Zboyan HA, et al. A double blind, placebo controlled study of the omega 3-fatty acid docosahexaenoic acid in the treatment of major depression. Am J Psychiatry. 2003;160(5) :996-998.
43. Mischoulon D, Papakostas GI, Dording CM, et al. A double blind, randomized controlled trial of ethyl eicosapentaenoate for major depressive disorder. J Clin Psychiatry. 2009;70(12):1636-1644.
44. Rees AM, Austin M Parker GB. Omega 3-fatty acids as a treatment for perinatal depression: randomized double blind placebo controlled trial. AustNzfPsychiatry. 2008;42(3):199-205.
45. Rogers PJ, Appleton KM, Kessler D, et al. No effect of n 3-long chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial. Brf Nutr. 2008;99(2):421-431.
46. Silvers KM, Woolley CC, Hamilton FC, et al. Randomised double blind placebo controlled trial of fish oil in the treatment of depression. Prostaglandins Leukot Essent Fatty Acids. 2005;72(3) :211-218.
47. Llorente AM, Jensen CL, Voigt RG, et al. Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol. 2003;188(5):1348-1353.
48. Makrides M, Gibson RA, McPhee AJ, et al; DOMInO Investigative Team. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA. 2010;304(15):1675-1683.
49. Martins JG. EPA but not DHA appears to be responsible for the efficacy of omega 3-long chain polyunsaturated fatty acid supplementation in depression: evidence from a meta analysis of randomized controlled trials. J Am Coil Nutr. 2009;28(5):525-542.
50. Ross BM, Seguin J, Sieswerda LE. Omega 3-fatty acids as treatments for mental Rlness: which disorder and which fatty acid? Lipids Health Dis. 2007;6(1):21.
51. Sublette ME, Ellis SP, Geant AL, et al. Meta analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. J Clin Psychiatry. 2011;72(12):1577-1584.
52. Hirschfeld RM. The comorbidity of major depression and anxiety disorders: recognition and management in primary care. Prim Care Companion J Clin Psychiatry. 2001;3(6):244-254.
53. Kessler RC, Chiu WT, Demler O, et al. Prevalence, severity, and comorbidity of 12-month DSM IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617-627.
54. Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age of onset distributions of DSM IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593-602.
55. Wang PS, Lane M, Olfson M, et al. Twelve month use of mental health services in the United States: results from the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):629-640.
56. Maes M, Smith R, Christophe A, et al. Fatty acid composition in major depression: decreased omega 3-fractions in cholesteryl esters and increased C20:4w6IC2O:5w3-ratio in cholesteryl esters and phospholipids. J Affect Disord. 1996;38(1):35-46.
57. Sublette ME, Bosetti F, DeMar JC, et al. Plasma free polyunsaturated fatty acid levels are associated with symptom severity in acute mania. Bipolar Disord. 2007;9(7):759-765.
58. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM IV Axis I Disorders. Washington, DC: American Psychiatric Press; 1996.
59. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56-62.
60. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561-571.
61. Grunebaum MF, Keilp J, Li S, et al. Symptom components of standard depression scales and past suicidal behavior. J Affect Disord. 2005;87(1):73-82.
62. Shafer AB. Meta analysis of the factor structures of four depression questionnaires: Beck, CES D, Hamilton, and Zung. J Clin Psychol. 2006;62(1):123-146.
63. Lepage G, Levy E, Ronco N, et al. Direct transesterification of plasma fatty acids for the diagnosis of essential fatty acid deficiency in cystic fibrosis. J Lipid Res. 1989;30(10):1483-1490.
64. Sublette ME, Segal Isaacson CJ, Cooper TB, et al. Validation of a food frequency questionnaire to assess intake of n 3-polyunsaturated fatty acids in subjects with and without major depressive disorder. J Am Diet Assoc. 2011;111(1):117-123.
65. Sublette ME, Galfalvy HC, Fuchs D, et al. Plasma kynurenine levels are elevated in suicide attempters with major depressive disorder. Brain Behav Immun. 2011;25(6):1272-1278.
66. Green P, Hermesh H, Monselise A, et al. Red cell membrane omega 3-fatty acids are decreased in nondepressed patients with social anxiety disorder. Eur Neuropsychopharmacol. 2006;16(2): 107-113.
67. Ross BM. Omega 3-polyunsaturated fatty acids and anxiety disorders. Prostaglandins Leukot Essent Fatty Acids. 2009;8-1(5-6):309-312.
68. Sanchez Villegas A, Henriquez P, Figueiras A, et al. Long chain omega 3-fatty acids intake, fish consumption and mental disorders in the SUN cohort study. Eur J Nutr. 2007;46(6):337-346.
69. Kiecolt Glaser JK, Belury MA, Andridge R, et al. Omega 3-supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial. Brain Behav Immun. 2011;25(8):1725-1734.
70. Buydens Branchey L, Branchey M. n 3-polyunsaturated fatty acids decrease anxiety feelings in a population of substance abusers. J Clin Psychopharmacol. 2006;26(6):661-665.
71. Buydens Branchey L, Branchey M, Hibbeln Jr. Associations between increases in plasma n 3-polyunsaturated fatty acids following supplementation and decreases in anger and anxiety in substance abusers. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(2) :568-575.
72. Yehuda S, Rabinovitz S, Mostofsky DI. Mixture of essential fatty acids lowers test anxiety. NutrNeurosci. 2005;8(4):265-267.
73. van de Rest O, Geleijnse JM, Kok FJ, et al. Effect of fish oil supplementation on mental well being in older subjects: a randomized, double blind, placebo controlled trial. Am J Clin Nutr. 2008;88(3):706-713.
74. Fux M, Benjamin J, Nemets B. A placebo controlled cross over trial of adjunctive EPA in OCD. J Psychiatr Res. 2004;38(3):323-325.
75. Zeev K, Michael M, Ram K, et al. Possible deleterious effects of adjunctive omega 3-fatty acids in post traumatic stress disorder patients. Neuropsychiatr Dis Treat. 2005;1(2):187-190.
76. Lespérance F, Frasure Smith N, St André E, et al. The efficacy of omega 3-supplementation for major depression: a randomized controlled trial. J Clin Psychiatry. 2011;72(8):1054-1062.
77. Carrie I, Clement M, de Javel D, et al. Phospholipid supplementation reverses behavioral and biochemical alterations induced by n 3-polyunsaturated fatty acid deficiency in mice. J Lipid Res. 2000;41(3):473-480.
78. Venna VR, Deplanque D, Allet C, et al. PUFA induce antidepressant like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology. 2009;34(2): 199-211.
79. Vinot N, Jouin M, Lhomme Duchadeuil A, et al. Omega 3-fatty acids from fish oil lower anxiety, improve cognitive functions and reduce spontaneous locomotor activity in a non human primate. PLoS ONE. 2011;6(6):e20491.
80. Fedorova I, Salem N Jr. Omega 3-fatty acids and rodent behavior. Prostaglandins Leukot Essent Fatty Acids. 2006;75(4-5):271-289.
81. Frances H, Monier C, Bourre JM. Effects of dietary alpha linolenic acid deficiency on neuromuscular and cognitive functions in mice. Life Sci. 1995;57(21):1935-1947.
82. Belzung C, Leguisquet AM, Barreau S, et al. Alpha linolenic acid deficiency modifies distractibility but not anxiety and locomotion in rats during aging. J Nutr. 1998;128(9):1537-1542.
83. Mathieu G, Oualian C, Denis I, et al. Dietary n 3-polyunsaturated fatty acid deprivation together with early maternal separation increases anxiety and vulnerability to stress in adult rats. Pro staglandins Leukot Essent Fatty Acids. 2011;85(3-4):129-136.
84. Harauma A, Moriguchi T. Dietary n 3-fatty acid deficiency in mice enhances anxiety induced by chronic mild stress. Lipids. 2011;46(5):409-416.
85. Bandaru SS, Lin K, Roming SL, et al. Effects of P13K inhibition and low docosahexaenoic acid on cognition and behavior. Physiol Behav. 2010;100(3):239-244.
86. Skouroliakou M, Konstantinou D, Koutri K, et al. A double blind, randomized clinical trial of the effect of omega 3-fatty acids on the oxidative stress of preterm neonates fed through parenteral nutrition. Eur J Clin Nutr. 2010;64(9):940-947.
87. Maes M, Song C, Lin A, et al. The effects of psychological stress on humans: increased production of pro inflammatory cytokines and a Thi like response in stress induced anxiety. Cytokine. 1998;10(4):313-318.
88. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732-741.
89. Kiecolt Glaser JK, Belury MA, Porter K, et al. Depressive symptoms, omega 6:omega 3-fatty acids, and inflammation in older adults. Psychosom Med. 2007;69(3):217-224.
90. Sullivan BL, Williams PG, Meyer BJ. Biomarker validation of a long chain omega 3-polyunsaturated fatty acid food frequency questionnaire. Lipids. 2006;41(9):845-850.